Skip to main content
  • People
  • Esse3
  • Online teaching
  • Libraries
Logo Unitn
MyUnitn
MyUnitn

  • Academic calendar
  • E learning
  • Job opportunities
  • Laboratories
  • Staff
DEPARTMENT
CELLULAR, COMPUTATIONAL AND INTEGRATIVE BIOLOGY - CIBIO
  • Department
    • Organization
    • Staff
    • Seminars
    • Job Opportunities
    • Quality
    • Rules and regulation
    • Press room
    • About us
    • How to reach us
  • Academics
    • Degrees
    • La valigetta del biotecnologo
    • Piano Nazionale Lauree Scientifiche (PNLS)
    • Percorso formazione insegnanti
    • Armenise-Harvard Summer Fellowships
  • Research
    • Programs
    • Laboratories
    • Core Facilities
    • Recent publications
  • Services
    • Teaching services
    • Enrolment and career
    • Other services
  • Third Mission
    • Fundraising
  • International mobility
    • Going abroad
    • Coming to Trento
 
  • Condividi questa pagina
Facebook Google Plus LinkedIn Twitter Mail Whatsapp 
Home | Research | Laboratories | Cancer Biology & Genomics | Laboratory of Computational and Functional Oncology

Laboratory of Computational and Functional Oncology

  • Programs
  • Laboratories
    • Cancer Biology & Genomics
      • Armenise-Harvard Cancer Biology & Genetics
      • Armenise-Harvard Laboratory of Brain Disorders and Cancer
      • Bioinformatics and Computational Genomics
      • Biotechnology and nanomedicine
      • Cell Biology and Molecular Genetics
      • Chromatin Biology & Epigenetics
      • Computational and Functional Oncology
      • Experimental Cancer Biology
      • Genomic Screening
      • Radiobiology
      • Metabolism of Cell Growth and Neuronal Survival
      • Molecular Cancer Genetics
      • Protein Crystallography and Structure-based Drug Design
      • RNA Regulatory Networks
      • Stem Cells and Cancer Genomics
      • Translational Genomics
      • Transcriptional Networks
    • Cell and Molecular Biology
      • Armenise-Harvard Laboratory of Cell Division
      • Biophysics and Translational Cardiology
      • Chromosome Segregation Biology
      • Computational Modeling
      • Dulbecco Telethon Prions and Amyloids
      • Molecular and Cellular Neurobiology
      • Molecular Virology
      • Molecular and Cellular Ophthalmology
      • RNA and Disease Data Science
      • RNA Biology and Biotechnology
      • Virus-Cell Interaction
    • Microbiology and Synthetic Biology
      • Armenise-Harvard Synthetic and Reconstructive Biology
      • Artificial Biology
      • Bacterial Genetics & Physiology
      • Computational Metagenomics
      • Microbial Genomics
      • Synthetic and Structural Vaccinology
    • Neurobiology & Development
      • Armenise-Harvard Axonal Neurobiology
      • Dulbecco Telethon Biology of Synapses
      • Dulbecco Telethon Stem Cells and Regenerative Medicine
      • Neural Development and Regeneration
      • NeuroEpigenetics
      • Neurogenomic Biomarkers
      • Stem Cell Biology
      • Transcriptional Neurobiology
      • Translational Neurogenetics
      • Synaptic Plasticity
  • Core Facilities
  • Recent publications

Overview

Our research focuses on understanding how genetic diversity and genomic aberrations contribute to tumor evolution and progression. The final goal is to advance the field of Precision Oncology by identifying biomarkers to predict progression, to select pharmacological treatment and to monitor cancer patients’ treatment response, through the integration of tissue and liquid biopsy-based studies. The laboratory integrates large-scale experimental and computational work with main focus on GU cancers and is involved in international collaborative studies on prostate cancer.
Laboratory website demichelislab.eu The SPICE project

Research Projects

  • To short list synthetic lethal combinations via pan-cancer ad hoc computational analyses of thousands of human sequenced tumors, followed by in vitro validation and characterization of relevant hits (funded by ERC, MIUR, FTRT);

  • To identify the molecular features involved in the trans-differentiation of prostate cancer adenocarcinoma to AR indifferent phenotype, including to neuroendocrine phenotype (funded by NIH, PCF);

  • To study the effect of inherited variants within transcriptionally active regions and chromatin regulators on molecularly defined prostate cancer sub-classes (funded by AIRC);

  • To study the effect of somatic alterations and inherited variants in DNA repair genes on prostate cancer aggressiveness (funded by MIUR, FTRT);

  • To develop multi-analyte liquid biopsies tools spanning cell-free DNA genomics and methylation, and circulating extra-cellular vesicles for translational and clinical research in prostate and breast cancers (funded by NIH, PCF, CRUK-AIRC-Accelerator Award, Fondazione Caritro).

Group members

  • Francesca Demichelis, PI
  • Riccardo Bevilacqua, PhD student (exp.)
  • Thomas Cantore, PhD student (comp.)
  • Yari Ciani, post-doc (comp.)
  • Giacomo D’Amato, research fellow (comp.)
  • Giulia Fracassi, PhD student (exp.)
  • Gian Marco Franceschini, PhD student (comp.)
  • Paola Gasperini, post-doc (exp.)
  • Francesca Lorenzin, post-doc (exp.)
  • Angela Martinelli, research fellow (exp.)
  • Vera Mugoni, post-doc (exp.)
  • Caterina Nardella, program manager
  • Francesco Orlando, PhD student (comp.)
  • Marta Paoli, PhD student (comp.)
  • Orsetta Quaini, research fellow (exp.)
  • Simone Tomasini, research fellow (exp.)
  • Federico Vannuccini, PhD student (comp.)
  • Alessia Villani, research fellow (exp.)

Open positions are available, please contact: f.demichelis [at] unitn.it

Collaborations

  • Gert Attard, UCL, London
  • Himisha Beltran, DFCI, Boston
  • Matteo Benelli, Prato, Italy
  • Dolores Di Vizio, Cedars-Sinai, Los Angeles
  • ​Olivier Elemento, Weill Cornell Medicine, New York
  • Bishoy Faltas, Weill Cornell Medicine, New York
  • Helmut Klocker, University Hospital Innsbruck, Innsbruck
  • Mark A Rubin, University of Bern, Bern

Selected publications (2011-2017)

Ciani Y, Fedrizzi T, Prandi D, Lorenzin F, Locallo A, Gasperini P, Franceschini GM, Benelli M, Elemento O, Fava LL, Inga A, Demichelis F. Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer. Cell Syst. 2021 Oct 26:S2405-4712(21)00383-5. doi: 10.1016/j.cels.2021.10.001.

Benelli M, Franceschini GM, Magi A, Romagnoli D, Biagioni C, Migliaccio I, Malorni L, Demichelis F. Charting differentially methylated regions in cancer with Rocker-meth. Commun Biol. 2021 Nov 2;4(1):1249. doi: 10.1038/s42003-021-02761-3.

Wu A, Cremaschi P, Wetterskog D, Conteduca V, Franceschini GM, Kleftogiannis D, Jayaram A, Sandhu S, Wong SQ, Benelli M, Salvi S, Gurioli G, Feber A, Pereira MB, Wingate AM, Gonzalez-Billalebeitia E, De Giorgi U, Demichelis F., Lise S, Attard G. Genome-wide plasma DNA methylation features of metastatic prostate cancer. J Clin Invest. 2020 Apr 1;130(4):1991-2000. doi: 10.1172/JCI130887.

Beltran H, Romanel A, Conteduca V, Casiraghi N, Sigouros M, Franceschini GM, Orlando F, Fedrizzi T, Ku SY, Dann E, Alonso A, Mosquera JM, Sboner A, Xiang J, Elemento O, Nanus DM, Tagawa ST, Benelli M, Demichelis F. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. J Clin Invest. 2020 Apr 1;130(4):1653-1668. doi: 10.1172/JCI131041.

Persi E, Prandi D, Wolf YI, Pozniak Y, Barnabas GD, Levanon K, Barshack I, Barbieri C, Gasperini P, Beltran H, Faltas BM, Rubin MA, Geiger T, Koonin EV, Demichelis F., Horn D. Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues. Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16987-16996. doi: 10.1073/pnas.1908790116. Epub 2019 Aug 6.

Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM, Sboner A, Fedrizzi T, Mosquera JM, Robinson BD, De Sarkar N, Kunju LP, Tomlins S, Wu YM, Nava Rodrigues D, Loda M, Gopalan A, Reuter VE, Pritchard CC, Mateo J, Bianchini D, Miranda S, Carreira S, Rescigno P, Filipenko J, Vinson J, Montgomery RB, Beltran H, Heath EI, Scher HI, Kantoff PW, Taplin ME, Schultz N, deBono JS, Demichelis F., Nelson PS, Rubin MA, Chinnaiyan AM, Sawyers CL. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6.

Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen C-C, Wongvipat J, Ku S-Y, Gao D, Cao Z, Shah N, Adams EJ, Abida W, Watson PA, Prandi D, Huang C-H, de Stanchina E, Lowe SW, Ellis L, Beltran H, Rubin MA, Goodrich DW, Demichelis F., Sawyers CL. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 and RB1 deficient prostate cancer. Science. 2017 Jan 6;355(6320):84-88.

Romanel A, Garritano S, Stringa B, Blattner M, Dalfovo D, Chakravarty D, Cotter KA, Petris G, Dhingra P, Gasperini P, Cereseto A, Elemento O, Sboner A, Khurana E, Inga A, Rubin MA, Demichelis F. Inherited determinants of early recurrent somatic mutations in prostate cancer. Nat Commun. 2017 Jun 29;8(1):48.

Rubin MA, Girelli G, Demichelis F. Genomic Correlates to the newly proposed Grading Prognostic Groups for Prostate Cancer. Eur Urol. 2016 Apr;69(4):557-60.

Beltran H &, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BV, Varambally S, Tomlins SA, Nanus DM, Tagawa ST, Van Allen EM, Elemento O, Sboner A, Garraway L., Rubin MA., Demichelis F. Divergent clonal evolution of androgen receptor indifferent castration resistant prostate cancer. Nat Med. 2016 Mar;22(3):298-305.

Faltas BM, Prandi D, Tagawa ST, Molina AM, Nanus DM, Sternberg C, Rosenberg J, Mosquera J-M, Robinson B, Elemento O, Sboner A, Beltran H., Demichelis F., Rubin MA.. Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma. Nat Genet. 2016 Dec;48(12):1490-1499.

Francesca Demichelis, PI
via Sommarive n. 9, 38123 Povo (TN)
Ph. 
+39 0461 285305
Fax 
+39 0461 283937
f.demichelis [at] unitn.it